Form 4: Willis Towers Watson Executive Julie Jarecke Gebauer Reports Share Transaction

Julie Jarecke Gebauer, Head of Health, Wealth & Career at Willis Towers Watson, reports the withholding of shares by the issuer related to the vesting of performance-based restricted share units.

Summary

• On July 22, 2024, Julie Jarecke Gebauer, Head of Health, Wealth & Career at Willis Towers Watson PLC, reported a transaction involving ordinary shares of the company.
• The transaction involved the withholding of 1,669 shares by the issuer to cover the vesting and settlement of previously reported earned performance-based restricted share units at a price of $263.13 per share.
• Following the transaction, Ms. Gebauer directly owns 72,253.079 ordinary shares.
• She also indirectly owns 534 ordinary shares through the Dane Adam Gebauer Management Trust UA Feb 18, 2012, and another 534 ordinary shares through the Jeffrey Austin Gebauer Management Trust UA Feb 18, 2012.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing, indicating a neutral sentiment. It simply reports a transaction without expressing any positive or negative outlook.

Industry Context

This filing is a routine disclosure of insider transactions, which are common in publicly traded companies. It provides transparency into the trading activities of company executives.

Comparison to Industry Standards

• Form 4 filings are standard practice for publicly traded companies and their executives, ensuring compliance with SEC regulations.
• Similar filings are made by executives at companies like Aon and Mercer, which are major competitors of Willis Towers Watson in the consulting and brokerage space.

Stakeholder Impact

• The transaction has a minimal direct impact on shareholders, as it is a routine adjustment of share ownership related to executive compensation.
• The transaction has no impact on employees, customers, suppliers, or creditors.

Key Dates